174 related articles for article (PubMed ID: 24019799)
1. Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis.
Kamat SS; Kumar GS; Koshy AV
Dent Res J (Isfahan); 2013 May; 10(3):321-7. PubMed ID: 24019799
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of CK8 and CK18 in leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma: an immunohistochemistry study.
Nanda KD; Ranganathan K; Devi U; Joshua E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):245-53. PubMed ID: 22677743
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study.
Al-Dhohorah T; Mashrah M; Yao Z; Huang J
Eur J Histochem; 2016 Jun; 60(2):2629. PubMed ID: 27349317
[TBL] [Abstract][Full Text] [Related]
6. DNA content abnormality in oral submucous fibrosis concomitant leukoplakia: A preliminary evaluation of the diagnostic and clinical implications.
Xiao X; Hu Y; Li C; Shi L; Liu W
Diagn Cytopathol; 2020 Nov; 48(11):1111-1114. PubMed ID: 32433822
[TBL] [Abstract][Full Text] [Related]
7. Role of osteopontin in oral epithelial dysplasia, oral submucous fibrosis and oral squamous cell carcinoma.
Salati NA; Sharma M; Rao NN; Shetty SS; Radhakrishnan RA
J Oral Maxillofac Pathol; 2023; 27(4):706-714. PubMed ID: 38304518
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Palani J; Lakshminarayanan V; Kannan R
Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma.
A G D; Janardanan-Nair B; B R V
J Clin Exp Dent; 2017 Dec; 9(12):e1418-e1424. PubMed ID: 29410757
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis.
Jyothi Meka N; Ugrappa S; Velpula N; Kumar S; Naik Maloth K; Kodangal S; Ch L; Goyal S
J Dent Res Dent Clin Dent Prospects; 2015; 9(3):166-74. PubMed ID: 26697149
[TBL] [Abstract][Full Text] [Related]
12. [Cell morphometric analysis in oral submucous fibrosis, leukoplakia and squamous cell carcinoma].
Gao S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 May; 27(3):145-7, 189. PubMed ID: 1292898
[TBL] [Abstract][Full Text] [Related]
13. Expression of β-catenin in oral leukoplakia and oral submucous fibrosis: An immunohistochemical study.
Chowdhury P; Nagamalini BR; Singh J; Ashwini BK; Sharada ; Swaminathan U
J Oral Maxillofac Pathol; 2021; 25(1):124-130. PubMed ID: 34349422
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin expression in oral submucous fibrosis--an immunohistochemical study.
Ranganathan K; Kavitha R; Sawant SS; Vaidya MM
J Oral Pathol Med; 2006 Jan; 35(1):25-32. PubMed ID: 16393250
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of oral submucous fibrosis in Taiwan: A nationwide population-based retrospective cohort study.
Yang PY; Chen YT; Wang YH; Su NY; Yu HC; Chang YC
J Oral Pathol Med; 2017 Nov; 46(10):1040-1045. PubMed ID: 28295637
[TBL] [Abstract][Full Text] [Related]
16. Qualitative expression of hypoxia-inducible factor-1α in malignant transformation of oral submucous fibrosis: An immunohistochemical study.
Pereira T; Surve R; Shetty S; Gotmare S
J Oral Maxillofac Pathol; 2020; 24(1):106-112. PubMed ID: 32508457
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis.
Rajendran R; Varkey S
Indian J Dent Res; 2007; 18(3):94-100. PubMed ID: 17687170
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
19. Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan.
Chiang CP; Lang MJ; Liu BY; Wang JT; Leu JS; Hahn LJ; Kuo MY
Oral Oncol; 2000 Jul; 36(4):353-9. PubMed ID: 10899674
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Blebbing Frequency in Tobacco-Induced Oral Potentially Malignant Disorders: A Pilot Study.
Yadahalli R; Kheur S; Adwani A; Bhonde R; Raj AT; Patil S
Acta Cytol; 2021; 65(5):403-410. PubMed ID: 34120116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
